NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Andy Koenig
Pfizer Inc. - New York / United States
Others
AD Scientific Index ID: 4391174
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Andy Koenig's MOST POPULAR ARTICLES
1-)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double …P Emery, FC Breedveld, S Hall, P Durez, DJ Chang, D Robertson, ...The Lancet 372 (9636), 375-382, 200810072008
2-)
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised …JS Smolen, P Nash, P Durez, S Hall, E Ilivanova, F Irazoque-Palazuelos, ...The Lancet 381 (9870), 918-929, 20134122013
3-)
Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double‐blind …M Dougados, D van der Heijde, J Sieper, J Braun, WP Maksymowych, ...Arthritis & rheumatology 66 (8), 2091-2102, 20142222014
4-)
Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double‐blind trialJ Braun, IE van der Horst‐Bruinsma, F Huang, R Burgos‐Vargas, ...Arthritis & Rheumatism 63 (6), 1543-1551, 20112192011
5-)
Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studiesIE van der Horst-Bruinsma, DJ Zack, A Szumski, AS KoenigAnnals of the rheumatic diseases 72 (7), 1221-1224, 20131842013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept